Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.25	52.65	49.09
Graham Fair Price	0.36	68.17	67.92
PEG	-60.44	1.78	-4.49
Price/Book	33.13	10.18	7.65
Price/Cash Flow	188.25	136.51	47.36
Prices/Earnings	12.87	15.73	13.93
Price/Sales	30.15	11.37	8.74
Price/FCF	188.25	136.51	47.36
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.12	0.37	0.34
Operating Margin	21.11	0.22	0.18
ROA	11.49	0.03	0.03
ROE	0.14	0.16	17.95
ROIC	0.04	0.05	14.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.04	-55.94
Dividends QOQ	< 0.005	< 0.005	-96.32
EBIT QOQ	-0.09	0.12	32.41
EPS QOQ	-0.03	0.09	185.32
FCF QOQ	-0.04	-0.58	-1368.21
Revenue QOQ	0.02	-0.07	381.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	131.89	153.78	16.60
Days Sales Outstanding (DSO)	100.52	107.88	7.32
Inventory Turnover	0.68	0.59	-14.23
Debt/Capitalization	0.66	0.68	3.18
Quick Ratio	0.80	0.75	-6.72
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38.65	35.71	-7.59
Cash	17.60	10.85	-38.35
Capex	-1.69	-1.49	11.99
Free Cash Flow	6.24	2.66	-57.32
Revenue	33.84	31.99	-5.48
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.35	1.35	-0.23
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.56	8.15	-4.76
Naive Interpretation	Member

06 - Financial Health · Weak

Rating